ZD4054 (Zibotentan)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ZD4054 (Zibotentan), covering 2012-05-31 to 2012-09-03. Get the full timeline:
Most recent: Clinical Trial Update: ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) [Phase 2]